ArticleRespiratory research2017

Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.

Toshio Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.